ASRNL:EURONEXT AMSTERDAMASR Nederland N.V. Analysis

ASR Nederland is trading at €67.8, comfortably above its 20‑day (66.03) and 50‑day (65.53) simple moving averages and the 200‑day average (61.05), indicating a bullish price trend. The RSI sits at 59.8 and the MACD histogram is positive (0.06) with a bullish signal, reinforcing short‑term momentum, while the beta of 0.34 suggests the stock is less volatile than the market. However, volume is decreasing, which could limit upside in the near term. Valuation metrics are mixed: the trailing P/E of 31.4 is well above the industry average of 17.4, yet the forward P/E of 10.8 and a modest upside of ~2.4% versus the DCF fair value point to a near‑fair valuation. The dividend yield is attractive at 5.1%, but a payout ratio of 149% raises concerns about sustainability. On the balance sheet, ASR holds €92.3 bn of cash against €24.2 bn of debt, resulting in a high debt‑to‑equity ratio of 239%, though net cash remains strong. Operating margins are healthy (35% operating margin, 52% gross margin) but profit margins are thin (3.2%) and operating cash flow is negative, offset by positive free cash flow. Revenue growth of 9.5% and a forward EPS outlook of €6.28 suggest growth potential, while the low beta (0.34) and sector stability temper overall risk. The “Extreme Greed” market sentiment (fear‑greed index 91.25) adds a bullish bias, but regulatory and sector‑specific risks inherent to the diversified insurance industry remain.